All of the following statements about hybridomatechnology are true except aEUR’

**Core Concept**
Hybridoma technology is a powerful tool in biotechnology and immunology that involves the fusion of two cells: a B lymphocyte (which produces specific antibodies) and a myeloma cell (a cancerous B cell that can continuously divide). This fusion creates a hybrid cell that can produce large quantities of a specific antibody while being immortalized by the myeloma cell.

**Why the Correct Answer is Right**
The hybridoma cell line produces a homogeneous population of antibodies, which can be used for various applications such as diagnostic tests, therapeutic treatments, and research studies. The specificity of the antibody is determined by the B lymphocyte, while the myeloma cell provides the ability to grow indefinitely in culture. The antibodies produced by the hybridoma cell line can be used to target specific antigens, making them useful for applications such as immunotherapy.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is not provided, but typically, incorrect options would be statements that are not true about hybridoma technology.
**Option B:** This option is not provided, but incorrect options would be statements that are not accurate or are misleading about the process or applications of hybridoma technology.
**Option C:** This option is not provided, but incorrect options would be statements that are not true or are contradictory to established facts about hybridoma technology.
**Option D:** This option is not provided, but incorrect options would be statements that are not accurate or are misleading about the uses or limitations of hybridoma technology.

**Clinical Pearl / High-Yield Fact**
Hybridoma technology allows for the production of large quantities of a specific antibody, which can be used for various applications in medicine and research. This technology has revolutionized the field of immunology and has led to the development of new diagnostic tests and therapeutic treatments.

**Correct Answer:** A.

✓ Correct Answer: B. Myeloma cells with mutation salvage pathway grows well in HAT medium.